| Lastest Insider Transactions Of Spero Therapeutics, Inc. ( SPRO ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | See Remarks | 2026-05-04 | Sell | 25,240 | 2.51 | 63,352 | 2026-05-06 21:53:26 |
| SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | See Remarks | 2026-02-06 | Sell | 87,917 | 2.36 | 207,484 | 2026-02-09 21:31:37 |
| SPRO | Spero Therapeutics, Inc. | Keutzer Timothy | Chief Operating Officer | 2026-02-06 | Sell | 18,652 | 2.36 | 44,019 | 2026-02-09 21:09:39 |
| SPRO | Spero Therapeutics, Inc. | Keutzer Timothy | Chief Operating Officer | 2026-02-02 | Sell | 46,586 | 2.17 | 101,175 | 2026-02-05 06:30:03 |
| SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | See Remarks | 2026-02-02 | Sell | 18,442 | 2.20 | 40,572 | 2026-02-04 21:44:22 |
| SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | See Remarks | 2025-11-07 | Sell | 40,270 | 2.37 | 95,440 | 2025-11-12 20:44:50 |
| SPRO | Spero Therapeutics, Inc. | Mahadevia Ankit | Directior | 2025-08-28 | Sell | 6,572 | 1.97 | 12,947 | 2025-09-03 06:04:03 |
| SPRO | Spero Therapeutics, Inc. | Keutzer Timothy | Chief Operating Officer | 2025-08-28 | Sell | 1,695 | 1.97 | 3,339 | 2025-09-03 06:02:55 |
| SPRO | Spero Therapeutics, Inc. | Keutzer Timothy | Chief Operating Officer | 2025-02-03 | Sell | 56,537 | 0.78 | 44,099 | 2025-02-05 21:04:51 |
| SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | CFO & CBO | 2025-02-03 | Sell | 20,689 | 0.78 | 16,137 | 2025-02-05 20:52:39 |
| SPRO | Spero Therapeutics, Inc. | Shukla Sath | CEO & President | 2025-02-03 | Sell | 155,333 | 0.78 | 121,160 | 2025-02-05 20:31:31 |
| SPRO | Spero Therapeutics, Inc. | Mahadevia Ankit | Directior | 2025-02-05 | Sell | 69,219 | 0.78 | 53,991 | 2025-02-05 20:30:24 |
| SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | CFO & CBO | 2024-11-07 | Sell | 40,596 | 1.31 | 53,008 | 2024-11-12 16:05:10 |
| SPRO | Spero Therapeutics, Inc. | Keutzer Timothy | Chief Operating Officer | 2024-02-01 | Sell | 30,971 | 1.36 | 42,121 | 2024-02-05 20:53:34 |
| SPRO | Spero Therapeutics, Inc. | Mahadevia Ankit | Directior | 2024-02-02 | Sell | 63,795 | 1.37 | 87,399 | 2024-02-05 20:50:09 |
| SPRO | Spero Therapeutics, Inc. | JOSEPH TAMARA L | Chief Legal Officer | 2024-02-01 | Sell | 30,906 | 1.37 | 42,341 | 2024-02-05 20:48:40 |
| SPRO | Spero Therapeutics, Inc. | HAMED KAMAL | Chief Medical Officer | 2024-02-01 | Sell | 28,075 | 1.37 | 38,463 | 2024-02-05 20:45:12 |
| SPRO | Spero Therapeutics, Inc. | Shukla Sath | CEO and President | 2024-02-01 | Sell | 75,994 | 1.42 | 107,719 | 2024-02-05 20:40:36 |
| SPRO | Spero Therapeutics, Inc. | HAMED KAMAL | Chief Medical Officer | 2023-09-13 | Sell | 39,496 | 1.27 | 50,160 | 2023-09-15 17:47:27 |
| SPRO | Spero Therapeutics, Inc. | Keutzer Timothy | Chief Development Officer | 2023-08-28 | Sell | 1,854 | 1.26 | 2,336 | 2023-08-30 16:23:33 |
| SPRO | Spero Therapeutics, Inc. | JOSEPH TAMARA L | Chief Legal Officer | 2023-08-28 | Sell | 1,854 | 1.26 | 2,336 | 2023-08-30 16:22:54 |
| SPRO | Spero Therapeutics, Inc. | Mahadevia Ankit | Directior | 2023-08-28 | Sell | 9,040 | 1.26 | 11,390 | 2023-08-30 16:21:03 |
| SPRO | Spero Therapeutics, Inc. | Shukla Sath | CEO and President | 2023-08-28 | Sell | 6,017 | 1.29 | 7,748 | 2023-08-30 16:20:21 |
| SPRO | Spero Therapeutics, Inc. | Mahadevia Ankit | CEO and President | 2023-02-03 | Sell | 12,286 | 1.81 | 22,238 | 2023-02-06 16:15:11 |
| SPRO | Spero Therapeutics, Inc. | Keutzer Timothy | Chief Operating Officer | 2023-02-01 | Sell | 3,394 | 1.86 | 6,313 | 2023-02-03 19:43:51 |
| SPRO | Spero Therapeutics, Inc. | JOSEPH TAMARA L | Chief Legal Officer | 2023-02-01 | Sell | 3,394 | 1.86 | 6,313 | 2023-02-03 19:43:02 |
| SPRO | Spero Therapeutics, Inc. | Shukla Sath | Chief Financial Officer | 2023-02-01 | Sell | 9,504 | 1.83 | 17,372 | 2023-02-03 19:41:41 |
